Jangik I. Lee

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Su Young Jung, Sun-Jin Hwang, Jeffery M. Clarke et al. · Investigational New Drugs · 2019 · 76 citations

Medicine, Oncology, Pharmacokinetics +13

Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients

Min Jung Chang, Jung‐woo Chae, Hwi‐yeol Yun et al. · Tuberculosis · 2014 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors

Su Young Jung, Ji Seob Yug, Jeffery M. Clarke et al. · Cancer Chemotherapy and Pharmacology · 2019 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +9

Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors

Chulho Lee, Jee Sun Yang, Bo‐Young Joe et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia

Jihyun Lee, Su Young Jung, Mi‐Yeon Choi et al. · Journal of Clinical Pharmacy and Therapeutics · 2020 · 17 citations

Pharmacy, Hematology, Pharmacology +16